Skip to main content
Journal cover image

Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine.

Publication ,  Journal Article
Thomas, DM; Fox, S; Lorgelly, PK; Ashley, D; Richardson, G; Lipton, L; Parisot, JP; Lucas, M; McNeil, J; Wright, M; Cancer 2015 Investigators,
Published in: Drug Discov Today
December 2015

Genomic cancer medicine promises revolutionary change in oncology. The impacts of 'personalized medicine', based upon a molecular classification of cancer and linked to targeted therapies, will extend from individual patient outcomes to the health economy at large. To address the 'whole-of-system' impact of genomic cancer medicine, we have established a prospective cohort of patients with newly diagnosed cancer in the state of Victoria, Australia, about whom we have collected a broad range of clinical, demographic, molecular, and patient-reported data, as well as data on health resource utilization. Our goal is to create a model for investigating public investment in genomic medicine that maximizes the cost:benefit ratio for the Australian community at large.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Drug Discov Today

DOI

EISSN

1878-5832

Publication Date

December 2015

Volume

20

Issue

12

Start / End Page

1429 / 1432

Location

England

Related Subject Headings

  • Prospective Studies
  • Precision Medicine
  • Neoplasms
  • Medicine
  • Medicinal & Biomolecular Chemistry
  • Longitudinal Studies
  • Humans
  • Genomics
  • Australia
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, D. M., Fox, S., Lorgelly, P. K., Ashley, D., Richardson, G., Lipton, L., … Cancer 2015 Investigators, . (2015). Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine. Drug Discov Today, 20(12), 1429–1432. https://doi.org/10.1016/j.drudis.2015.10.009
Thomas, David M., Stephen Fox, Paula K. Lorgelly, David Ashley, Gary Richardson, Lara Lipton, John P. Parisot, et al. “Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine.Drug Discov Today 20, no. 12 (December 2015): 1429–32. https://doi.org/10.1016/j.drudis.2015.10.009.
Thomas DM, Fox S, Lorgelly PK, Ashley D, Richardson G, Lipton L, et al. Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine. Drug Discov Today. 2015 Dec;20(12):1429–32.
Thomas, David M., et al. “Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine.Drug Discov Today, vol. 20, no. 12, Dec. 2015, pp. 1429–32. Pubmed, doi:10.1016/j.drudis.2015.10.009.
Thomas DM, Fox S, Lorgelly PK, Ashley D, Richardson G, Lipton L, Parisot JP, Lucas M, McNeil J, Wright M, Cancer 2015 Investigators. Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine. Drug Discov Today. 2015 Dec;20(12):1429–1432.
Journal cover image

Published In

Drug Discov Today

DOI

EISSN

1878-5832

Publication Date

December 2015

Volume

20

Issue

12

Start / End Page

1429 / 1432

Location

England

Related Subject Headings

  • Prospective Studies
  • Precision Medicine
  • Neoplasms
  • Medicine
  • Medicinal & Biomolecular Chemistry
  • Longitudinal Studies
  • Humans
  • Genomics
  • Australia
  • 3214 Pharmacology and pharmaceutical sciences